Longevo
Assesses monogenic predispositions, selected risk scores, and pharmacogenomics to support more individualized prevention.
- 155 genes and more than 100 conditions.
- Monogenic and polygenic risk.
- Pharmacogenomics and recommendations for clinical discussion.